To assess the changes in CSF sTREM2 during the pathology of PD, patients were classified through the A/T classification framework with addition of α-synuclein (α-syn), which we implemented based on the CSF amyloid β-peptide 1−42 (A) and phosphorylated tau (T) and α-syn (S). This evidence concerns the gene SNCA and Parkinson disease.